|

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

RECRUITINGSponsored by University Hospital, Linkoeping
Actively Recruiting
SponsorUniversity Hospital, Linkoeping
Started2021-05-17
Est. completion2026-02-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04783701

Summary

The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Previously included in TACSI-trial

Exclusion Criteria:

* Highly irregular heart rhythm (i.e. atrial fibrillation)
* Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<45ml/min/1,73m2
* Body weight \>120 kg
* Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents
* Not able to communicate
* Not willing to participate

Conditions3

Acute Coronary SyndromeCoronary Bypass StenosisHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.